| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 07/19/2001 | WO2001051083A2 Innate immunity-stimulating compositions of cpg and saponin and methods thereof |
| 07/19/2001 | WO2001051082A1 Composition of antigen and glycolipid adjuvant sublingual administration |
| 07/19/2001 | WO2001051081A1 In vivo ctl elicitation by heat shock protein fusion proteins maps to a discrete atp binding domain and is cd4+ t cell-independent |
| 07/19/2001 | WO2001051080A2 Methods and compositions for obtaining disease protection for animals |
| 07/19/2001 | WO2001051079A1 Antigen-specific ige antibody production inhibitors |
| 07/19/2001 | WO2001051077A1 Methods of regulating il-12 production by administering ccr5 agonists and antagonists |
| 07/19/2001 | WO2001051070A1 Physiologically active substance eem-s originating in mushrooms, process for producing the same and drugs |
| 07/19/2001 | WO2001051068A1 Method and device for increasing and/or decreasing the concentration of immunomodulatory-active substances in substance mixtures |
| 07/19/2001 | WO2001051062A1 Compositions for enhancing the immune response |
| 07/19/2001 | WO2001051049A1 O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders |
| 07/19/2001 | WO2001051044A2 Substances for use in treating psoriasis |
| 07/19/2001 | WO2001051014A1 Pharmaceutical and cosmetic carrier or composition for topical application |
| 07/19/2001 | WO2001051008A2 Selective activation of a th1 or th2 lymphocyte regulated immune response |
| 07/19/2001 | WO2001051003A2 Use of lipid conjugates in the treatment of disease |
| 07/19/2001 | WO2001050873A1 Thickened oil compositions of edible oil |
| 07/19/2001 | WO2001050848A2 Clonal propagation of primate offspring by embryo splitting |
| 07/19/2001 | WO2001005969A3 Electron transfer proteins |
| 07/19/2001 | WO2001004297A3 Human proteins having hydrophobic domains and dnas encoding these proteins |
| 07/19/2001 | WO2001004271A3 Respiratory syncytial viruses expressing immune modulatory molecules |
| 07/19/2001 | WO2000074716A3 Ige peptides for allergy immunotherapy |
| 07/19/2001 | WO2000073324A3 Modulation of gene expression in gastrointestinal inflammation |
| 07/19/2001 | WO2000055321B1 Vertebrate protein slit, dna sequence encoding it and uses thereof |
| 07/19/2001 | WO2000041474A3 Anti-cd3 immunotoxins and therapeutic uses therefor |
| 07/19/2001 | WO2000025808A9 Inhibition of differentiation of cytotoxic t-cells by p-selectin ligand (psgl) antagonists |
| 07/19/2001 | WO2000009616A8 Biologically active fraction of vegetable melanin, process for its production and its use |
| 07/19/2001 | WO2000006198A3 Adjuvant comprising pulmonary surfactant |
| 07/19/2001 | WO1998033916A8 Secreted proteins and polynucleotides encoding them |
| 07/19/2001 | US20010008901 Nitrile derivatives that inhibit cathepsin K |
| 07/19/2001 | US20010008888 Pharmaceutical compositions for the treatment of transplant rejection, autoimmune or inflammatory conditions comprising cyclosporin a and 40-O-(2-hydroxyethyl)-rapamycin |
| 07/19/2001 | US20010008759 Contacting target cells with member of antibody phage display library |
| 07/19/2001 | CA2823768A1 Hybrid cells |
| 07/19/2001 | CA2397741A1 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 07/19/2001 | CA2397707A1 Compositions for enhancing the immune response |
| 07/19/2001 | CA2397481A1 Irak-4: compositions and methods of use |
| 07/19/2001 | CA2397396A1 Methods and compositions for obtaining disease protection for animals |
| 07/19/2001 | CA2397374A1 Innate immunity-stimulating compositions of cpg and saponin and methods thereof |
| 07/19/2001 | CA2397340A1 Drug metabolizing enzymes |
| 07/19/2001 | CA2397334A1 Secreted proteins |
| 07/19/2001 | CA2397081A1 Novel vitamin d analogues |
| 07/19/2001 | CA2397068A1 Pharmaceutical and cosmetic carrier or composition for topical application |
| 07/19/2001 | CA2397053A1 Human and parasite orphan receptor proteins |
| 07/19/2001 | CA2396966A1 Methods for synthesis of .alpha.-d-gal (1.fwdarw.3) gal-containing oligosaccharides |
| 07/19/2001 | CA2396962A1 Benzosulfones and related compositions and methods |
| 07/19/2001 | CA2396889A1 Novel peptide and screening method by using the same |
| 07/19/2001 | CA2396384A1 In vivo ctl elicitation by heat shock protein fusion proteins maps to a discrete atp binding domain and is cd4+ t cell-independent |
| 07/19/2001 | CA2396247A1 Clonal propagation of primate offspring by embryo splitting |
| 07/19/2001 | CA2396237A1 Selective activation of a th1 or th2 lymphocyte regulated immune response |
| 07/19/2001 | CA2396087A1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 07/19/2001 | CA2396071A1 Thickened oil compositions of edible oil |
| 07/19/2001 | CA2395975A1 Inhibitors of the ice/ced-3 family of cysteine proteases |
| 07/18/2001 | EP1115877A1 Polynucleotide constructs and uses thereof |
| 07/18/2001 | EP1115875A1 Human complement c3-degrading polypeptide from streptococcus pneumoniae |
| 07/18/2001 | EP1115864A2 Human chaperone proteins |
| 07/18/2001 | EP1115860A2 Membrane-associated organizational proteins |
| 07/18/2001 | EP1115847A1 Short peptides which selectively modulate the activity of protein kinases |
| 07/18/2001 | EP1115743A1 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use |
| 07/18/2001 | EP1115735A1 31 human secreted proteins |
| 07/18/2001 | EP1115720A2 Novel n-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them |
| 07/18/2001 | EP1115719A2 Novel amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same |
| 07/18/2001 | EP1115712A1 Oxazole compounds as prostaglandin e2 agonists or antagonists |
| 07/18/2001 | EP1115708A1 Aminoalkyl-3,4-dihydroquinoline derivates as no-synthase inhibitors |
| 07/18/2001 | EP1115707A1 Benzamide derivatives and ther use as cytokine inhibitors |
| 07/18/2001 | EP1115703A1 Cyclic ester or amide derivatives |
| 07/18/2001 | EP1115702A1 Substituted nitrogen and sulfur alicyclic compounds, including methods for synthesis thereof |
| 07/18/2001 | EP1115697A1 Unsaturated hydroximic acid derivatives as parp inhibitors |
| 07/18/2001 | EP1115427A1 Time-staggered utilization of tumor cells in combination with intact antibodies for immunization |
| 07/18/2001 | EP1115425A1 Autoantibody inhibitors |
| 07/18/2001 | EP1115423A1 Methods of downmodulating the immune response to therapeutic proteins |
| 07/18/2001 | EP1115411A1 Extract of nerium species, pharmaceutical composition thereof and methods for preparation thereof |
| 07/18/2001 | EP1115410A1 Isolation of nutrient-rich carotenoids and their formulations |
| 07/18/2001 | EP1115405A1 Use of certain drugs for treating nerve root injury |
| 07/18/2001 | EP1115398A1 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| 07/18/2001 | EP1115396A1 Pharmaceutically active compounds and methods of use thereof |
| 07/18/2001 | EP1115383A1 Pharmaceutical composition for the treatment of acute disorders |
| 07/18/2001 | EP1115372A2 Fast dissolving orally consumable films |
| 07/18/2001 | EP1034171B1 Pseudopolymorphic forms of 2-[2-[4-[bis(4-fluorophenyl)methyl]-1-piperazinyl]ethoxy]acetic acid dihydrochloride |
| 07/18/2001 | EP1033369A4 5H-PYRANO [2,3-d:6,5-d']DIPYRIMIDINE DERIVATIVES HAVING AN ANTIBACTERIAL, ANTIVIRAL AND IMMUNO-MODULATING ACTIVITY |
| 07/18/2001 | EP0667787B1 Group b streptococcus type ii and type v polysaccharide-protein conjugate vaccines |
| 07/18/2001 | EP0636025B1 Compounds useful for treating allergic or inflammatory diseases |
| 07/18/2001 | CN1304442A Delivery of proteins into eukaryotic cells with recombinant Yersinia |
| 07/18/2001 | CN1304316A Adenovirus vector containing heterologous peptide epitope in HI loop of fiber knob |
| 07/18/2001 | CN1304315A Use of cyclosporins in treatment of inflammatory autoimmune diseases |
| 07/18/2001 | CN1304312A Composition and method for treatment and preventing of arthritis and/or autoimmune diseases |
| 07/18/2001 | CN1303930A Novel polypeptide-zinc finger protein 57 and polynucleotide coding said polypeptide |
| 07/18/2001 | CN1303866A Novel polypeptide-zinc finger protein 36 and polynucleotide for coding this polypeptide |
| 07/18/2001 | CN1303864A Novel polypeptide-zinc finger protein 60 and polynucleotide for coding said polypeptide |
| 07/18/2001 | CN1068591C 1,3-dihydro-1-(phenylalkyl)-2H-imdiazol-2-one derivatives having PDEIV and cytokine activity |
| 07/18/2001 | CN1068590C 1,3-dihydro-1-(phonylalkenyl)-2H-imidazol-2-one derivatives having PDEIV and cytokine inhibiting activity |
| 07/17/2001 | US6262246 DNA encoding mammalian neuropeptides FF (NPFF) receptors and uses thereof |
| 07/17/2001 | US6262244 Genes coding for the extracellular part of four specific nkg2 (natural killer) transmembrane proteins; useful in treating infectious diseases and cancer |
| 07/17/2001 | US6262172 Method for preparing a carbonized resin DNA immunoadsorbent |
| 07/17/2001 | US6262127 Polymeric matrices and their uses in pharmaceutical compositions |
| 07/17/2001 | US6262119 Methods of treating immunopathologies using polyunsaturated fatty acids |
| 07/17/2001 | US6262112 Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases |
| 07/17/2001 | US6262107 Conjugated to a water soluble polyglutamic acid polymer |
| 07/17/2001 | US6262104 Selective delta opioid agonists and antagonists |
| 07/17/2001 | US6262096 Aminothiazole inhibitors of cyclin dependent kinases |
| 07/17/2001 | US6262084 Compounds that inhibit the binding of integrins to their receptors |
| 07/17/2001 | US6262075 Piperidone tachykinin antagonists |
| 07/17/2001 | US6262066 High affinity ligands for nociceptin receptor ORL-1 |